|
Pierre-Andre Chavaillaz, Ph.D., Director, Product Development
Dr. Chavaillaz was a member of the scientific team Sunol Molecular Corporation in 1996, where his research focused on recombinant antibody production, particularly the generation of recombinant mammalian cell lines for large-scale production of human-mouse chimeric antibodies as well as fully human antibodies. He joined Altor in 2005, where he is responsible for managing development of the production cell line for Altor’s single chain, soluble T-cell receptor proteins. His earlier research was conducted at Baxter Healthcare and Dade International, where he generated several human-mouse heteromyeloma cell lines for use in monoclonal antibody production and he was a collaborator on three issued patents for novel proteins. Dr. Chavaillaz holds a Master’s Degree in organic chemistry from the University of Fribourg in Switzerland, where he also earned his doctorate in biochemistry. He obtained post-doctoral training at the University of Sherbrooke, Quebec, Canada, and at the University of Bern, Switzerland. | 